Pear Therapeutics, Novartis announce commercial launch of reSET
Mobi Health News
NOVEMBER 20, 2018
As the first prescription digital therapeutic approved by the FDA, the treatment will be distributed and supported by a specialist-staffed service center.
Let's personalize your content